Physician profile
Robert Stone Baxt
NPI 1285684704
$1,000.88
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $210 · 2021: $271 · 2022: $342 · 2023: $177.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $177.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $176.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $613.98 | 2021-2023 | Grafix Pl, Oasis |
| Organogenesis INC. | $123.51 | 2021 | |
| Allergan, INC. | $105.14 | 2019 | |
| Abbvie INC. | $38.00 | 2019-2021 | |
| Triad Life Sciences INC. | $28.26 | 2022 | |
| Novartis Pharmaceuticals Corporation | $21.14 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $16.02 | 2019 | |
| Novo Nordisk INC | $14.45 | 2019 | |
| Assertio Therapeutics, INC. | $13.73 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $12.65 | 2019 | |
| Lilly USA, LLC | $11.71 | 2019 | |
| Kerecis Limited | $2.29 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Baxt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.